Day: August 20, 2025

Data to highlight the impact of Wegovy® (semaglutide 2.4 mg) on atrial fibrillation – a common heart rhythm condition – in people living with obesity (SELECT study) Additional Rybelsus® and Ozempic® data demonstrate new cardiometabolic benefits (improvements in heart and metabolic health) in people living with type 2 diabetes (SOUL and STRIDE studies) New insights into the role of inflammation in cardiovascular disease on mortality and major cardiovascular events in people living with inflammation in the heart vesselsBagsværd, Denmark, 20 August 2025 – Novo Nordisk today announced new data showing the cardiovascular protective benefits of Wegovy® and Ozempic® will be presented at the European Society of Cardiology (ESC) Congress 2025 from 29 August to 1 September in Madrid, Spain. New data will also include perspectives on the role...

Approval Facilitates Immediate Offshored and Outsourced Manufacturing Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to Outsourced Production Reduces Fixed Costs and Supports Trinity’s Broader Profitability and Growth Objectives DUBLIN, Aug. 20, 2025 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that the in-country healthcare product regulatory authority has granted the key approval to initiate offshore and outsourced manufacturing of its flagship World Health Organization (WHO) prequalified TrinScreen™ HIV rapid test. This key approval now enables Trinity Biotech to transition...

NEWBURYPORT, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) — UFP Technologies, Inc. (UFPT), today announced Mitch Rock, President, and Ron Lataille, Sr. VP and CFO, will present at the Midwest IDEAS Investor Conference on Tuesday, August 26, 2025, at The InterContinental in Chicago, IL. UFP’s presentation is scheduled to begin at 7:55 AM CT. The presentation is webcast and can be accessed through the conference host’s main website: https://www.threepartadvisors.com/midwest and in the Investor Relations section of the company’s website: http://www.ufpt.com. About IDEAS Investor Conferences The mission of the IDEAS Conferences is to provide independent regional venues for quality companies to present their investment merits to an influential audience of investment professionals. Unlike traditional bank-sponsored events, IDEAS Investor...

SAN DIEGO, Aug. 20, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today announced the pricing of an underwritten public offering for gross proceeds of $6 million prior to deducting underwriting commissions and offering expenses. “We are extremely pleased to have priced this transaction despite difficult market conditions,” said Eric Poma, Chief Executive Officer of Calidi Biotherapeutics. “This transaction included participation from current shareholders and new investors as well as management and board members.” The offering is comprised of (i) 1,472,764 common stock units with each unit...

Subscription-based platform expected to strengthen officer skills retention, reinforce Wrap’s pre-escalation mission, and open recurring revenue streams — pathways toward state-certified content in pre-escalation policing MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or, the “Company”), a global leader in pre-escalation and public safety solutions, today announced the official launch of WrapTactics™, a subscription-driven digital learning and training platform designed to modernize officer readiness through human-science-based instruction and burst learning modules. Research shows that police skills degrade rapidly without reinforcement—core defensive tactics can deteriorate within just two weeks, while firearms proficiency and de-escalation practices are often refreshed only once...

MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will participate in the H.C. Wainwright 27th Annual Global Investment Conference taking place September 8-10, 2025 in New York City.Details for the Company’s presentation:       Date: Monday, September 8, 2025  Time: 4:00 – 4:30 p.m. ET     The webcast for this conference presentation may be accessed at the “Events and Presentations” section of the Company’s website. A replay of the webcast will be available on the Longeveron website for 180 days following the conference. About Longeveron Inc.Longeveron is a clinical stage biotechnology company developing...

Kartoon Studios, in Partnership with Bitkern Group AG in Switzerland, Unveils a Bitcoin-Native Ecosystem that Combines Animated Entertainment, Interactive Rewards, and Educational Apps to Empower the Next Generation Kartoon Studios to Introduce Games, Coins, and Consumer Products Based on Series and Characters First Series to be Fully Produced in AI Features Anime Style Design and K-Pop Music Track BEVERLY HILLS, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) —  Kartoon Studios, Inc. (NYSE: TOON) (“Kartoon Studios” or the “Company”) today announces the launch of “Bitcoin Brigade: Adventures in Satoshi City,” a groundbreaking new property that is far more than an animated series. This revolutionary project is the centerpiece of a fully-integrated business model spanning content, digital education, merchandise, interactive apps, and a pioneering...

Company announcementfor ROCKWOOL A/S   Release no. 49 – 2025to Nasdaq Copenhagen 20 August 2025 ROCKWOOL adjusts outlook related to revenue and earnings for full-year 2025 To reflect the challenging market environment, ROCKWOOL adjusts the outlook for revenue and earnings for 2025 as follows:Revenue is expected to be at level with last year in local currencies, changed from previously revenue growth of low single-digit percent in local currencies. EBIT margin is expected to be below 16 percent, changed from previously around 16 percent.Main highlights for Q2 and H1 2025:Revenue in H1 2025 reached 1,947 MEUR, an increase of one percent measured in both local currencies and reported figures compared to last year. The 2024 acquisitions had a two-percentage point positive impact in H1 2025 compared to last year. Revenue in Q2 2025 reached...